newsfilter
← Latest News
GlobeNewswire·

Humacyte Announces Presentation of Symvess® Long-Term Safety and Efficacy Results at VESS Meeting

- Data presented at Annual Winter Meeting 2026 for the Vascular & Endovascular Surgery Society - - After up to 36 months of follow-up, extremity arterial trauma patients had high rates of limb salvage, low rates of